|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/17 | (2006.01) |
| A61K 38/10 | (2013.01) | ||
| A61P 15/10 | (2006.01) | ||
| A61K 38/1716 | (2013.01) | ||
| A61P 15/10 | (2018.01) |
| (11) | Number of the document | 3576772 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18707189.9 |
| Date of filing the European patent application | 2018-02-08 | |
| (97) | Date of publication of the European application | 2019-12-11 |
| (45) | Date of publication and mention of the grant of the patent | 2021-09-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2018/017349 |
| Date | 2018-02-08 |
| (87) | Number | WO 2018/160335 |
| Date | 2018-09-07 |
| (30) | Number | Date | Country code |
| 201715446406 | 2017-03-01 | US |
| (72) |
AVERBACK, Paul , BS
|
| (73) |
Nymox Corporation ,
777 Terrace Avenue, Hasbrouck Heights, NJ 07604,
US
|
| (54) | FEXAPOTID FOR IMPROVING SEXUAL FUNCTION |
| FEXAPOTID FOR IMPROVING SEXUAL FUNCTION |